EDT — Spectral Medical Share News
0.000.00%
Last trade - 00:00- CA$324.10m
- CA$348.98m
- CA$2.44m
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%
Brief: Spectral Medical Receives US$3 Million From Vantive
Brief: Spectral Medical Announces Second Quarter And Provides Corporate Update
Brief: Spectral Medical Announces Filing Of Base Shelf Prospectus Of Up To $100 Mln
Brief: Spectral Medical Announces Fourth Quarter And Fiscal 2024 Results And Provides Corporate Update
Brief: Spectral Medical Provides October Tigris Trial Update
Brief: Spectral Medical To Close Additional $1 Mln Convertible Notes
Brief: Spectral Medical Provides June Tigris Trial Update
Brief: Spectral Medical Provides Tigris Trial Update
Brief: Spectral Medical Chair To Retire From The Board Of Directors
Brief: Spectral Medical Inc. FY revenue CAD 1.598 million
Brief: Spectral Medical Provides February Tigris Trial Update
Brief: Spectral Medical Provides Early February Tigris Trial Update
Brief: Spectral Medical Provides January Tigris Trial Update
Brief: Spectral Medical Enrolls Patient 82 In Its Phase 3 FDA Tigris Septic Shock Trial
Brief: Spectral Medical Provides Tigris Trial Update